INS and type 1 diabetes mellitus: Whereas in some autoimmune disease specific antigen targets can be identified (e.g., insulin in type 1 diabetes), in other subtypes, including systemic sclerosis, the lack of one single autoantigen represents an obstacle for CAR-T cells’ efficacy.